VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma.
Dominic Kaddu-MulindwaMaciej RosolowskiMarita ZiepertEvi RegitzGunter AssmannMoritz BewarderGerhard HeldMichael PfreundschuhJörg Thomas BittenbringPublished in: European journal of haematology (2020)
Single-nucleotide polymorphisms of the VEGF and VEGFR2 were not associated with a worse outcome in Caucasian patients with DLBCL.